Acute cognitive tech Target organizations focused on cognitive assessment and brain health (e.g., hospitals, clinics, and research labs). Leverage the established MIT/Lahey lineage and AI-enabled bedside testing to position as a fast, non-invasive screening tool with scalable deployment.

Acquisition backdrop Note the 2021 acquisition by Linus Health, with DCTclock designed by Digital Cognition Technologies. This signals a mature product with integration potential into a larger cognitive health platform and possible partnerships or channel opportunities.

SMB friendly Small team size and low capital footprint suggest a lean, easily adoptable solution for mid-market healthcare providers seeking quick ROI and minimal IT burden, ideal for pilot programs and phased rollouts.

Cost efficient Product highlights include being non-invasive, inexpensive, <2 minutes per test, and requiring little counter space. Emphasize total cost of ownership, rapid revenue realization, and suitability for high-volume screening in clinics or elder care facilities.

Data partnerships Previous use of Framingham Heart Study normative data and AI integration presents an opportunity to pursue collaborations with academic medical centers, long-term care networks, and payer/ASC partnerships to enhance validation, reimbursement discussions, and broader market reach.